A biocompatible bismuth based metal-organic framework as efficient light-sensitive drug carrier

J Colloid Interface Sci. 2022 Jul:617:578-584. doi: 10.1016/j.jcis.2022.01.188. Epub 2022 Mar 9.

Abstract

The low toxicity and good photo active property endow bismuth based metal-organic frameworks (MOFs) potential candidates for efficient light-sensitive drug carrier. In this work, SU-101, composed of Bi and ellagic acid (EA), is found to display high ciprofloxacin (CIP) loading ratio (85.8%) and controlled CIP release under light illumination (the maximum CIP release ratio is 95.56%). Further investigations suggest that hydrogen bond between the CO group in EA and the -OH group in CIP is responsible for above behavior. Light irradiation decreases the electron density around the CO group in EA, which consequently leads to the broken of the hydrogen bond and therefore the release of CIP. Further investigations suggest that SU-101 is universal for other drugs, such as norfloxacin (NOR), amoxicillin (AMO), tetracycline (TET) and doxorubicinhydrochloride (DOX), since all of them can form hydrogen bond with SU-101. This work suggests that SU-101 holds great potential as efficient light-sensitive drug carrier, and the investigation of other Bi based MOFs as drug carrier is under investigation.

Keywords: Biocompatible materials; Bismuth based metal–organic framework; Controlled release; Drug carrier.

MeSH terms

  • Bismuth* / chemistry
  • Ciprofloxacin / chemistry
  • Drug Carriers / chemistry
  • Metal-Organic Frameworks* / chemistry
  • Tetracycline

Substances

  • Drug Carriers
  • Metal-Organic Frameworks
  • Ciprofloxacin
  • Tetracycline
  • Bismuth